ObvioHealth is a global digital health organization offering real-world digital clinical trials for enhanced data collection. The company's mobile clinical study application enables site-less trial design, allowing participants to engage in remote monitoring trials using their smartphones from their homes. This approach ensures continuous data collection, fostering robust data collection, increased compliance, faster recruitment, and improved time to completion. The app also facilitates communication through text messages and chatbot features, fostering participant engagement during virtual clinical trials. Additionally, it seamlessly integrates with various health devices and offers features like scheduling lab visits and facilitating compensation for decentralized clinical trials through PayPal. Founded in 2017 and headquartered in the United States, ObvioHealth received a Debt Financing investment on 01 January 2022. For more information, visit Obviohealth.com to discover how their technology can support observational and virtual clinical trials.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Debt Financing | Unknown | - | 01 Jan 2022 | |
Series B | Unknown | - | 08 Jun 2021 | |
Series A | Unknown | - | 31 Mar 2021 | |
Series A | Unknown | - | 14 Apr 2020 | |
Seed | Unknown | - | 23 Mar 2018 |
No recent news or press coverage available for ObvioHealth.